© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
An advanced study compared intravenous infusions and subcutaneous injections of the antibody treatment.
Around 90% of people treated with the immunomodulator did not develop cancer.
Having health insurance increases early detection and timely treatment for many cancers.
This special issue of Cancer Health focuses on multiple myeloma, a type of blood cancer that affects the bone marrow.
He believes that America has the resources to make drugs and treatment more affordable for everyone.
Their goal is to develop therapies to treat the disease
As treatment options evolve, so too does the push to better understand firefighters’ increased risk to certain cancers.
Incidence is increasing for six of 12 obesity-related cancers, including colorectal, kidney and pancreatic.
Isatuximab improved progression-free survival in a Phase III study.
Researchers propose using a less-than-one-in-a-million level—or the absence of minimal residual disease—to measure drugs’ effectiveness.
What’s more, such treatment is linked to remission of non–Hodgkin lymphoma.
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
